AUXILIUM PHARMACEUTICALS INC's ticker is AUXL and the CUSIP is 05334D107. A total of 153 filers reported holding AUXILIUM PHARMACEUTICALS INC in Q3 2014. The put-call ratio across all filers is 0.31 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2014 | $839,000 | +15.2% | 24,400 | 0.0% | 0.06% | +60.0% |
Q3 2014 | $728,000 | +48.9% | 24,400 | 0.0% | 0.04% | +73.9% |
Q2 2014 | $489,000 | -18.9% | 24,400 | +9.9% | 0.02% | -20.7% |
Q1 2014 | $603,000 | +31.1% | 22,200 | 0.0% | 0.03% | +45.0% |
Q4 2013 | $460,000 | – | 22,200 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Palo Alto Investors LP | 4,854,631 | $144,911,000 | 10.83% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 6,267,382 | $187,081,000 | 6.82% |
Consonance Capital Management LP | 1,493,560 | $44,583,000 | 6.12% |
Healthcare Value Capital, LLC | 200,000 | $5,970,000 | 5.76% |
Tiger Legatus Capital Management, LLC | 500,000 | $14,925,000 | 5.29% |
Tamarack Capital Management, LLC | 650,000 | $19,403,000 | 4.30% |
KING INVESTMENT ADVISORS INC/TX | 282,675 | $8,438,000 | 3.84% |
TIG Advisors, LLC | 2,799,913 | $83,577,000 | 3.21% |
Artal Group S.A. | 2,275,000 | $67,909,000 | 2.50% |
JET CAPITAL INVESTORS L P | 2,100,000 | $62,685,000 | 2.31% |